Home Depot Stock (NYSE:HD) News Today (Dec. 18, 2025): Dividend Day, 2026 Outlook, and Fresh Analyst Forecasts

Home Depot Stock (NYSE:HD) News Today (Dec. 18, 2025): Dividend Day, 2026 Outlook, and Fresh Analyst Forecasts

Home Depot (NYSE: HD) is back in focus on December 18, 2025, with investors weighing a mix of market-driven momentum, newer FY2026 growth targets, and a steady shareholder-return story anchored by today’s dividend payment. In afternoon trading, the stock hovered around $356 per share, down modestly versus the prior close, keeping it in the lower half of its 52‑week range after a volatile stretch for housing-linked names. Investing.com The day’s tape also shows why HD keeps showing up in market headlines: early gains in Home Depot were among the notable contributors lifting the price-weighted Dow during the session. MarketWatch Below
18 December 2025
Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (FRMI) Stock on Dec. 18, 2025: Amazon-Tenant Claims Clash With Company Denial as Analysts Recut Targets After Project Matador Setback

Fermi Inc (NASDAQ & LSE: FRMI) is having the kind of week that turns a normal stock chart into modern art: sharp gaps, headline-driven swings, and investors trying to separate what’s confirmed from what’s merely energetic speculation. On December 18, 2025, FRMI closed at $8.34, down 7.98% on the day, after opening near $9.31 and trading as high as $9.33 and as low as $8.27—with roughly 7.52 million shares changing hands. Investing.com That move sits on top of an even bigger story: Fermi’s “first tenant” financing arrangement for its flagship Project Matador in Texas was terminated last week, triggering a
18 December 2025
Bloom Energy Stock (NYSE:BE) Rebounds on Fuel-Cell Rally and Cooling Inflation: Dec. 18 News, Analyst Forecasts, and What Investors Are Watching

Bloom Energy Stock (NYSE:BE) Rebounds on Fuel-Cell Rally and Cooling Inflation: Dec. 18 News, Analyst Forecasts, and What Investors Are Watching

Dec. 18, 2025 — Bloom Energy Corporation’s stock swung sharply again Thursday as investors weighed a powerful mix of macro tailwinds, fuel-cell sector momentum, and still-heated debate over valuation. Shares finished Dec. 18 at $81.63, up from $76.97 the prior session—an advance of roughly 6% day over day after a turbulent week for AI-linked and power-infrastructure names. Yahoo Finance+1 What happened to Bloom Energy stock on Dec. 18, 2025 Bloom Energy shares gapped up at the open and traded through a wide range before cooling into the close. According to historical pricing data, BE opened at $82.91, hit an intraday
18 December 2025
Shopify Stock Jumps on Analyst Price-Target Upgrades and Cooling Inflation — What’s Next for SHOP Shares (Dec. 18, 2025)

Shopify Stock Jumps on Analyst Price-Target Upgrades and Cooling Inflation — What’s Next for SHOP Shares (Dec. 18, 2025)

Shopify Inc. shares rallied on Thursday, December 18, as a fresh wave of Wall Street price-target increases collided with a friendlier macro backdrop for growth stocks. Shopify’s U.S.-listed shares (NASDAQ: SHOP) were up 3.6% to $167.56 in mid-afternoon pricing (as of 2:16 p.m. ET, delayed), after touching an intraday high of $172.96. The move pushed the stock to within roughly 8% of its 52-week high. Shopify Investors Investors have two clear narratives to digest today: a cluster of bullish analyst updates that revived the “$200 target” conversation, and a cooler U.S. inflation print that strengthened hopes the Federal Reserve can
Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal Closes Early, Dividend Paid, and 2026 Forecasts in Focus (Dec. 18, 2025)

Qualcomm (QCOM) Stock News Today: Alphawave Semi Deal Closes Early, Dividend Paid, and 2026 Forecasts in Focus (Dec. 18, 2025)

Qualcomm Incorporated (NASDAQ: QCOM) is back in the spotlight on Thursday, December 18, 2025, as investors digest two developments that matter to shareholders right now: the early close of Qualcomm’s Alphawave Semi acquisition and a cash dividend landing today—all while Wall Street keeps one eye on Qualcomm’s next earnings checkpoint and its expanding AI narrative. The day’s headlines are not just about a completed transaction—they’re about what Qualcomm is trying to become in 2026: a company that still dominates premium Android silicon, but also pushes deeper into AI infrastructure, custom CPUs, and data center connectivity, where the prize is measured
Intuit (INTU) Stock News Today: Circle USDC Stablecoin Deal, TurboTax Push, and Fresh Wall Street Forecasts (Dec. 18, 2025)

Intuit (INTU) Stock News Today: Circle USDC Stablecoin Deal, TurboTax Push, and Fresh Wall Street Forecasts (Dec. 18, 2025)

Intuit Inc. (NASDAQ: INTU) is in focus on Thursday, December 18, 2025, after announcing a multi-year partnership with Circle Internet Group to bring USDC stablecoin capabilities into Intuit’s ecosystem—TurboTax, QuickBooks, and Credit Karma—while also launching a new consumer-facing tax-season campaign aimed at boosting engagement and refunds. Intuit Investors+1 Key takeaways for INTU stock on Dec. 18, 2025 INTU’s headline news on Dec. 18: Intuit partners with Circle to bring USDC stablecoins to TurboTax, QuickBooks, and Credit Karma Intuit said Thursday it has formed a multi-year strategic partnership with Circle to incorporate stablecoin technology (USDC) across Intuit’s financial platforms. The company
18 December 2025
Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences Ltd. (NASDAQ: WVE) is back in the spotlight on December 18, 2025—not because of a brand-new press release, but because the stock is still digesting one of the most volatile biotech weeks of the year. In Thursday trading, WVE stock fell roughly mid-single digits, hovering in the mid-$15 range after closing around $16.34 the prior session, according to market data and widely circulated market recaps. StockAnalysis+1 That pullback matters because it comes right after a dramatic early-December surge tied to Wave’s obesity program—and immediately following a large equity financing that materially changes the company’s cash position and
18 December 2025
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stock slid sharply on Thursday, December 18, 2025, after a regulatory filing revealed a leadership transition involving the company’s Chief Medical and Development Officer. In trading, CRNX fell roughly 8% to around the mid‑$40s, with the day’s range stretching from the low‑$40s to the high‑$40s as investors digested the update. Investing.com For a biotech stock—especially one in the middle of a major product launch and multiple late‑stage trials—management continuity matters. But so do fundamentals: Crinetics is no longer “just” a clinical-stage story. It recently reached a pivotal milestone with its first FDA-approved product, and its
18 December 2025
Adobe Stock (ADBE) News, Forecasts and Analyst Outlook for Dec. 18, 2025: Citi Raises Target, FY2026 Guidance, and a New AI Copyright Lawsuit

Adobe Stock (ADBE) News, Forecasts and Analyst Outlook for Dec. 18, 2025: Citi Raises Target, FY2026 Guidance, and a New AI Copyright Lawsuit

Adobe Inc. (NASDAQ: ADBE) stock is back in the spotlight on Thursday, Dec. 18, 2025, as investors balance three forces that have increasingly defined the company’s narrative in late 2025: (1) a solid earnings-and-guidance package that leans on subscription durability, (2) a fast-evolving generative AI strategy designed to defend (and expand) Adobe’s creative and marketing software moat, and (3) rising legal and competitive risk tied to how AI systems are trained and monetized. Shares were trading around $354 on Thursday, with the session’s range extending roughly from the low $350s to the high $350s. Below is a detailed roundup of
18 December 2025
Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana Co. shares (NYSE: CVNA) bounced higher on Thursday, Dec. 18, as investors looked past recent volatility and refocused on two powerful themes: the company’s imminent addition to the S&P 500 and Wall Street’s still-constructive outlook on Carvana’s post-turnaround earnings trajectory. CVNA was last trading around $463, up roughly 3.8% on the day, after opening near $449 and touching an intraday high near $464. The timing matters. Carvana is heading into the final stretch before it officially joins the S&P 500, a milestone that can reshape the shareholder base through index-tracking demand. Meanwhile, analysts and investors are debating a harder
18 December 2025
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Incorporated (NYSE: UNH) stock is ending a volatile 2025 with fresh headline risk—and a handful of potentially meaningful catalysts—front and center on December 18, 2025. Shares traded around $326–$327 in midday trading, after moving between roughly $324.66 and $330.50 intraday. While UnitedHealth remains one of the most closely watched blue-chip healthcare names, 2025 has been defined by unusually wide investor debate about near-term earnings durability, regulatory risk, and the pace of normalization into 2026. By one Reuters-tracked measure, UNH’s year-to-date price return is roughly -32.6%—a drop that helps explain why even incremental “good news” headlines can move the
18 December 2025
Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

December 18, 2025 — Amphenol Corporation (NYSE: APH) is back in focus today as the stock steadies near the $130 level after a volatile stretch that has included sharp swings in volume, a pullback from recent highs, and fresh debate about whether the company’s AI-and-data-center tailwinds still justify a premium valuation. As of the latest available trading update on Dec. 18, 2025, APH shares were around $129 (day range roughly $126.7–$130.4), with a market cap near $156 billion. Amphenol stock price action: what’s happening on Dec. 18, 2025 Today’s story starts with context: on Wednesday, Dec. 17, Amphenol fell 2.03%
18 December 2025
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Dec. 18, 2025 — Birkenstock Holding plc (NYSE: BIRK) delivered a classic “beat-and-drop” session: strong fiscal 2025 results and record revenue were overshadowed by a more cautious fiscal 2026 outlook that bakes in tariff and currency pressure. SEC+1 As of the latest available trade on Dec. 18, Birkenstock shares were at $42.58, down about 8% on the day, after swinging between $39.73 and $46.75 in heavy volume. The market’s message was blunt: investors liked what Birkenstock just did, but they’re repricing what it may earn next—especially if tariffs and foreign-exchange (FX) headwinds prove sticky. What’s happening with Birkenstock stock today
Boeing (BA) Stock News Today: Dec. 18, 2025 Updates, Analyst Forecasts, and What’s Next for The Boeing Company

Boeing (BA) Stock News Today: Dec. 18, 2025 Updates, Analyst Forecasts, and What’s Next for The Boeing Company

December 18, 2025 — Boeing stock (NYSE: BA) is back in the spotlight as investors weigh a mix of near-term catalysts (labor talks tied to the Spirit AeroSystems integration) and longer-run drivers (production normalization, certification milestones, and a growing defense pipeline). In afternoon trading, Boeing shares were up about 1.4% around $209. Stock Analysis Below is a detailed, publication-ready breakdown of the biggest Boeing headlines on 18.12.2025, plus the latest consensus forecasts and the key signposts that could define BA’s next move. Boeing stock price action on Dec. 18, 2025 Boeing shares traded higher Thursday, hovering near $209 and rising
18 December 2025
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

December 18, 2025 — Edgewise Therapeutics, Inc. (NASDAQ: EWTX) saw its shares slide sharply in Thursday trading, a reminder that clinical-stage biotech stocks can move fast even when there’s no single headline screaming for attention. EWTX finished the session around $20.35, down roughly 8.8% from the prior close, after trading between about $20.33 and $22.81. StockAnalysis That drop matters because the Edgewise story is still mostly about future clinical readouts and regulatory path clarity, not current product revenue. The company is advancing late-stage work in muscular dystrophies (with its lead program, sevasemten) and also developing cardiac sarcomere modulators for conditions
Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture plc stock (NYSE: ACN) was lower Thursday after the consulting and IT services giant reported fiscal first-quarter 2026 results that topped Wall Street expectations—but delivered a second-quarter revenue outlook that, at the midpoint, came in slightly under analyst forecasts. As of the latest update Thursday afternoon, Accenture shares traded around $270.84, down about 1% from the prior close, after swinging between roughly $262.00 and $285.34 intraday. The market’s reaction underscores the split narrative surrounding Accenture stock in late 2025: strong demand for AI-led work is translating into faster “advanced AI” bookings and revenue, but investors remain alert to near-term
Salesforce (CRM) Stock News Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Acquisition, and Fresh Analyst Price Targets

Salesforce (CRM) Stock News Today (Dec. 18, 2025): Agentforce in ChatGPT, Qualified Acquisition, and Fresh Analyst Price Targets

December 18, 2025 — Salesforce, Inc. (NYSE: CRM) is ending the year with a familiar mix of catalysts that matter to stock investors: a new AI distribution channel, another targeted acquisition in its “agentic” strategy, and a steady drumbeat of analyst updates as Wall Street tries to put a price on the company’s next growth phase. As of 17:47 UTC on Thursday, Dec. 18, Salesforce shares traded at $257.52, down roughly 0.2% on the session. Below is a roundup of the major news, forecasts, and analyst takes circulating on Dec. 18, 2025, plus what they may mean for the CRM
18 December 2025
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries Incorporated (NYSE: ABM) stock was sharply lower in Thursday trading (December 18, 2025), with shares recently changing hands near $43.13, down about 10.6% from the prior close after a volatile session that saw the stock trade between $43.02 and $47.63. The move follows a dense burst of company updates released on December 17: ABM’s fiscal fourth-quarter and full-year 2025 results, a fiscal 2026 outlook, a dividend increase, and a major acquisition announcement—plus fresh analyst commentary today that put margins and leverage back at the center of the debate. GlobeNewswire+2ABM+2 Why ABM stock is moving today The immediate catalyst
Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer Stock (NYSE: PFE) News Today: 2026 Guidance, Analyst Price Targets, Medicare Pricing Pressure, and Pipeline Catalysts (Dec. 18, 2025)

Pfizer (NYSE: PFE) stock is trying to regain its footing on Thursday, December 18, 2025, after a volatile mid-December stretch that put the spotlight back on three recurring themes for shareholders: the post-COVID revenue reset, looming loss-of-exclusivity (LOE) headwinds, and whether Pfizer’s rebuilt pipeline can drive durable growth later this decade. As of 18:26 UTC (1:26 p.m. ET) on Dec. 18, Pfizer shares traded around $25.04, essentially flat on the day. What’s driving Pfizer stock on Dec. 18, 2025 Here are the major, market-moving Pfizer headlines and developments investors are digesting today: Pfizer stock price check: stability after a sharp
18 December 2025
Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

WASHINGTON — President Donald Trump signed a new executive order Thursday aimed at accelerating the federal reclassification of marijuana, a rare, headline-grabbing shift in U.S. drug policy that could ripple across medical research, the cannabis industry, and state-by-state enforcement. WHEC.com+1 But the marijuana move isn’t happening in isolation. On Dec. 18, 2025, multiple executive-order-driven storylines collided across Washington—from federal efforts to curb state AI regulation, to sweeping health-policy proposals tied to an earlier Trump order, to continued fallout from a proxy-voting order reshaping corporate governance debates. My Journal Courier+3The White House+3HHS+3 The big news today: Trump signs an executive order to fast-track
18 December 2025

Stock Market Today

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Go toTop